Skip to main content
Cytokinetics, Incorporated (CYTK)
NASDAQ: CYTK · Real-Time Price · USD
55.96
-0.23 (-0.41%)
Nov 13, 2024, 4:00 PM EST - Market closed

Cytokinetics Revenue

Cytokinetics had revenue of $463.00K in the quarter ending September 30, 2024, with 22.49% growth. This brings the company's revenue in the last twelve months to $3.22M, down -58.81% year-over-year. In the year 2023, Cytokinetics had annual revenue of $7.53M, down -92.04%.

Revenue (ttm)
$3.22M
Revenue Growth
-58.81%
P/S Ratio
n/a
Revenue / Employee
$7,610
Employees
423
Market Cap
6.60B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20237.53M-87.06M-92.04%
Dec 31, 202294.59M24.16M34.30%
Dec 31, 202170.43M14.60M26.15%
Dec 31, 202055.83M28.96M107.79%
Dec 31, 201926.87M-4.63M-14.71%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Bausch + Lomb 4.68B
Elanco Animal Health 4.45B
Jazz Pharmaceuticals 3.99B
Lantheus Holdings 1.50B
Ionis Pharmaceuticals 803.07M
Corcept Therapeutics 628.56M
Legend Biotech 455.99M
Blueprint Medicines 434.42M
Revenue Rankings

CYTK News

More News